Association of Health and Lifestyle Factors with Uterine Fibroids Among Saudi Women: A Case-control Study

Overview

Journal J Taibah Univ Med Sci

Specialty General Medicine

Date 2022 Oct 10

PMID 36212583

Authors

Reema Muawad

Rufaidah Dabbagh

Yasser Sabr

Affiliations

Soon will be listed here.

Abstract

Objectives: The objective of this study was to measure the association between uterine fibroids (UFs) and several risk factors (parity, miscarriage, diabetes, hypertension, physical activity, smoking, family history of UF and contraceptive pill use) among Saudi women.

Methods: A case-control study was conducted in 478 women at two medical centers in Riyadh. Cases were confirmed by ultrasound. Demographic and risk factor information was collected from interviews and medical records. The prevalence of risk factors was calculated with 95% confidence interval (CI). Unconditional logistic regression analysis was used to measure the associations between UFs and the risk factors.

Results: More than half the participants were obese. The average body mass index (BMI) was 31.2 (±6.81) for cases and 29.4 (±7.02) for controls. Women 40 years or older had four times the odds of UFs than women younger than 40 years (adjusted odds ratio [AOR] = 4.24, 95% CI = 2.63, 6.85). Having a family history of UFs was associated with 69% greater odds of UFs (AOR = 1.69, 95% CI = 1.02, 2.81). Being obese was associated with 74% greater odds of UFs (AOR = 1.74, 95% CI = 1.00, 2.59), whereas previous live births decreased the odds of UFs by 62% (AOR = 0.38, 95% CI = 0.19, 0.75).

Conclusions: This study identified risk factors associated with UFs in the Saudi population. Age over 40 years, obesity and a family history of UFs are important risk factors for UF, whereas parity appears to be protective against UF development in Saudi women. Early recognition of these risk factors is important to prevent UF complications.

Citing Articles

The Association Between Physical Activity and Uterine Leiomyoma and Its Symptoms: A Systematic Review and Meta-Analysis.

Birolim M, Souza S, Rodrigues R, da Silva D, Martinez-Vizcaino V, Mesas A Health Sci Rep. 2025; 8(2):e70487.

PMID: 39995801 PMC: 11847712. DOI: 10.1002/hsr2.70487.

Psychological distress and uterine fibroids: a bidirectional two-sample mendelian randomization study.

Han X, Wu T, Bian Y, Chen L, Feng X BMC Womens Health. 2024; 24(1):351.

PMID: 38890689 PMC: 11184690. DOI: 10.1186/s12905-024-03196-8.

Family History and Uterine Fibroid Development in Black and African American Women.

Langton C, Harmon Q, Baird D JAMA Netw Open. 2024; 7(4):e244185.

PMID: 38568693 PMC: 10993075. DOI: 10.1001/jamanetworkopen.2024.4185.

Empowering Strategies for Lifestyle Interventions, Diet Modifications, and Environmental Practices for Uterine Fibroid Prevention; Unveiling the LIFE UP Awareness.

Vafaei S, Alkhrait S, Yang Q, Ali M, Al-Hendy A Nutrients. 2024; 16(6).

PMID: 38542717 PMC: 10975324. DOI: 10.3390/nu16060807.

Evaluation of the relationship between ovarian reserve with congenital anomalies and intramural uterine leiomyoma among infertile women: a cross-sectional study.

Moini A, Kalhor M, Jahanian Sadatmahalleh S, Niknejadi M, Nasiri M, Yahyaei A J Ovarian Res. 2023; 16(1):68.

PMID: 37024902 PMC: 10080793. DOI: 10.1186/s13048-023-01149-7.

References

Selo-Ojeme D, Lawal O, Shah J, Mandal R, Pathak S, Selo-Ojeme U . The incidence of uterine leiomyoma and other pelvic ultrasonographic findings in 2,034 consecutive women in a north London hospital. J Obstet Gynaecol. 2008; 28(4):421-3. DOI: 10.1080/01443610802149863. View

Sato F, Mori M, Nishi M, Kudo R, Miyake H . Familial aggregation of uterine myomas in Japanese women. J Epidemiol. 2002; 12(3):249-53. PMC: 10499479. DOI: 10.2188/jea.12.249. View

Velez Edwards D, Hartmann K, Wellons M, Shah A, Xu H, Edwards T . Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure. BMC Womens Health. 2017; 17(1):28. PMC: 5387248. DOI: 10.1186/s12905-017-0386-y. View

Stewart E, Cookson C, Gandolfo R, Schulze-Rath R . Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124(10):1501-1512. DOI: 10.1111/1471-0528.14640. View

Lumbiganon P, Rugpao S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y . Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study. Br J Obstet Gynaecol. 1996; 103(9):909-14. DOI: 10.1111/j.1471-0528.1996.tb09911.x. View

Baird D, Dunson D, Hill M, Cousins D, Schectman J . High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100-7. DOI: 10.1067/mob.2003.99. View

Thomas D . Sample size determination in case-control studies: the influence of the distribution of exposure. J Chronic Dis. 1985; 38(7):559-68. DOI: 10.1016/0021-9681(85)90044-x. View

Kampjarvi K, Park M, Mehine M, Kim N, Clark A, Butzow R . Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat. 2014; 35(9):1136-41. DOI: 10.1002/humu.22612. View

Cermik D, Arici A, Taylor H . Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma. Fertil Steril. 2002; 78(5):979-84. DOI: 10.1016/s0015-0282(02)03366-6. View

10.

Wise L, Laughlin-Tommaso S . Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin Obstet Gynecol. 2016; 59(1):2-24. PMC: 4733579. DOI: 10.1097/GRF.0000000000000164. View

11.

Williams A . Uterine fibroids - what's new?. F1000Res. 2017; 6:2109. PMC: 5721931. DOI: 10.12688/f1000research.12172.1. View

12.

Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F . Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2017; 46:3-11. DOI: 10.1016/j.bpobgyn.2017.09.004. View

13.

Townsend D, Sparkes R, BALUDA M, McClelland G . Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970; 107(8):1168-73. DOI: 10.1016/s0002-9378(15)30365-3. View

14.

Chiaffarino F, Ricci E, Cipriani S, Chiantera V, Parazzini F . Cigarette smoking and risk of uterine myoma: systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015; 197:63-71. DOI: 10.1016/j.ejogrb.2015.11.023. View

15.

Ajabnoor G, Mohammed N, Banaganapalli B, Abdullah L, Bondagji O, Mansouri N . Expanded Somatic Mutation Spectrum of MED12 Gene in Uterine Leiomyomas of Saudi Arabian Women. Front Genet. 2019; 9:552. PMC: 6302612. DOI: 10.3389/fgene.2018.00552. View

16.

Templeman C, Marshall S, Clarke C, Delellis Henderson K, Largent J, Neuhausen S . Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril. 2008; 92(4):1436-1446. PMC: 2765807. DOI: 10.1016/j.fertnstert.2008.08.074. View

17.

Donnez J, Dolmans M . Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22(6):665-686. PMC: 5853598. DOI: 10.1093/humupd/dmw023. View

18.

Clemmons D . Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov. 2007; 6(10):821-33. DOI: 10.1038/nrd2359. View

19.

Hashimoto K, Azuma C, Kamiura S, Kimura T, Nobunaga T, Kanai T . Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest. 1995; 40(3):204-8. DOI: 10.1159/000292336. View

20.

Lurie S, Piper I, Woliovitch I, Glezerman M . Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol. 2005; 25(1):42-4. DOI: 10.1080/01443610400024583. View